US

Wei-Wei Chang

This inventor holds 0 USPTO granted patents, plus 8 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Wei Chang. Retrieved from https://idiyas.com/inventor/wei-wei-chang-sjvlxlag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Wei-Wei Chang: Innovator in Cannabinoid Treatments

Introduction

Wei-Wei Chang is an innovative inventor based in the United States. He has made significant contributions to the field of medical treatments, particularly focusing on the use of cannabinoids for various health conditions. Although he currently holds no patents, his work has the potential to impact many lives.

Latest Patents

Wei-Wei Chang's latest patents include a method for treating radiotherapy- and chemotherapy-associated cognitive or emotional impairment with cannabinoids. This method involves topically administering a cannabinoid to specific areas of the face or the back of the neck, excluding the palpebral part of the eye. The goal is to provide relief from cognitive or emotional impairments induced by these treatments. Another notable invention is related to progesterone compositions and treatment for eye diseases and disorders. This invention provides compositions comprising progesterone and methods for treating ocular surface diseases by applying these compositions topically.

Career Highlights

Throughout his career, Wei-Wei Chang has worked with various companies, including Sunny Pharmtech Inc. and Glia, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Wei-Wei Chang has collaborated with notable professionals, including Kenneth I Sawyer. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Wei-Wei Chang is a dedicated inventor whose work in cannabinoid treatments and eye disease therapies showcases his commitment to improving health outcomes. His innovative approaches have the potential to make a significant difference in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…